Literature DB >> 6431162

Immunosuppressive activity of sera from gastric cancer patients.

M Sakita, T Torii, S Imaki, M Kasuga, M Tamai, G Suzuki, M Kano, Y Fujita, S Majima.   

Abstract

Sera from 60 gastric cancer patients and 20 patients with benign gastric diseases and 8 healthy controls were tested for inhibitory effects on the humoral response to sheep erythrocytes (SRBC) by the plaque forming cell assay (PFC R.I.) using mouse spleen cells and on the phytohemagglutinin (PHA)-induced blastogenesis of normal mouse spleen cells (PHA S.R.). Gastric cancer patient sera showed a significantly lower PFC R.I. than did sera from benign gastric disease patients and from the healthy controls. However, there was no appreciable interstage difference in the degree of depression. The PHA-induced blastogenesis of normal spleen cells was also decreased in the presence of sera from cancer patients, as compared to that in the presence of sera from benign disease patients and from the healthy controls. The depression progressed with advancing stage of cancer. The PHA S.R. showed significant negative correlations with serum levels of IAP, IS, alpha 1-acid glycoprotein and alpha 1-antitrypsin, but there were no such correlations between PFC R.I. and these glycoproteins in serum. There was also no correlation between the values of the PHA S.R. and the PFC R.I. These results suggest that these two assays may depict immunosuppressive activities operating through entirely different mechanisms.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6431162     DOI: 10.1007/bf02469803

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  12 in total

1.  Lymphocyte responsiveness to phytohemagglutinin and its modification by serum inhibitor in breast cancer patients.

Authors:  T Toge; Y Nagusa; A Nakano; H Ikeda; T Hattori
Journal:  Gan       Date:  1979-04

Review 2.  Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens.

Authors:  K E Hellström; I Hellström
Journal:  Adv Immunol       Date:  1974       Impact factor: 3.543

3.  Competitive blockade of lymphocyte stimulation by a serum immuno-regulatory alpha globulin (IRA).

Authors:  S R Cooperband; R C Davis; K Schmid; J A Mannick
Journal:  Transplant Proc       Date:  1969-03       Impact factor: 1.066

4.  Phytohaemagglutinin-stimulated transformation of peripheral and lymph-node lymphocytes in patients with gastro-intestinal cancer.

Authors:  P J Guillou; T G Brennan; G R Giles
Journal:  Br J Surg       Date:  1973-09       Impact factor: 6.939

5.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

6.  Further improvements in the plaque technique for detecting single antibody-forming cells.

Authors:  A J Cunningham; A Szenberg
Journal:  Immunology       Date:  1968-04       Impact factor: 7.397

7.  Isolation and characterization of an immunosuppressive acidic protein from ascitic fluids of cancer patients.

Authors:  K Tamura; Y Shibata; Y Matsuda; N Ishida
Journal:  Cancer Res       Date:  1981-08       Impact factor: 12.701

8.  Serum immunosuppression test as a new tool for immunodiagnosis of lung cancer.

Authors:  T Izumi; S Nagai; T Suginoshita
Journal:  Cancer Res       Date:  1980-02       Impact factor: 12.701

9.  Depression of macrophage function by a factor produced by neoplasms: a merchanism for abrogation of immune surveillance.

Authors:  M C Pike; R Snyderman
Journal:  J Immunol       Date:  1976-10       Impact factor: 5.422

10.  Serum mediated inhibition of the immunological reactions of the patient to his own tumour: a possible role for circulating antigen.

Authors:  G A Currie; C Basham
Journal:  Br J Cancer       Date:  1972-12       Impact factor: 7.640

View more
  2 in total

1.  Preoperative serum immunosuppressive acidic protein (IAP) test for the prognosis of gastric cancer: a statistical study of the threshold level and evaluation of the effect of the biological response modifier PSK.

Authors:  J Sakamoto; A Koike; S Saji; S Teramukai; Y Ohashi; H Nakazato
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

2.  Antitumor effect of intratumoral administration of biological response modifiers: induction of immunosuppressive acidic protein, a type of alpha 1-acid glycoprotein, in mice.

Authors:  T Ebina; K Murata; K Tamura
Journal:  Jpn J Cancer Res       Date:  1994-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.